From Medscape HIV/AIDS

Coverage from

HIV Drug Therapy 2018

October 28 - 31, 2018; Glasgow, United Kingdom

October 28 - 31, 2018 Glasgow, United Kingdom

HIV 2018 HIV Rates Still Rising in Eastern Europe and Central Asia HIV rates are dropping all over the world, but Eastern Europe and Central Asia are being left behind. But basics such as test-and-treat programs can make a difference, experts say.
Medscape Medical News, October 29, 2018

Conference News

HIV 2018 Jury Still Out on Neural Tube Defects From Dolutegravir
Medscape Medical News, November 6, 2018
HIV 2018 New HIV Viral Suppression After 24 Weeks for Fostemsavir
Medscape Medical News, November 5, 2018
HIV 2018 Cardiovascular Risk Unclear for HIV Patients on Dolutegravir
Medscape Medical News, October 30, 2018

HIV 2018 HIV Rates Still Rising in Eastern Europe and Central Asia
Medscape Medical News, October 29, 2018
HIV 2018 Treating Resistant HIV, Patient-Centered Care at HIV Glasgow
Medscape Medical News, October 22, 2018

Popular HIV News

INSTI-based Two-Drug Antiretroviral Effective for New HIV The once-a-day antiretroviral regimen for patients new to treatment works and is safe, early results from the ongoing GEMINI trials suggest.
Medscape Medical News, Jul 30, 2018
Protease Inhibitors in Patients With HIV, HF May Up CV Mortality Readmission for heart-failure decompensation and cardiovascular death are more likely for patients with HIV on antiretrovirals who are also taking protease inhibitors, suggests a single-center study.
Medscape Medical News, Jul 26, 2018
Women Tackle Tough Choice After Dolutegravir Birth Defects The antiretroviral taken at the time of conception has been linked to neural tube defects in babies, but a blanket ban of the drug for all women of childbearing age strikes some as discriminatory.
Medscape Medical News, Jul 25, 2018

Medscape HIV/AIDS© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

Related Resource

HIV Transmission, Prevention News & Perspectives